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Background: Extensive use of antibiotics has fostered the emergence of superbugs that are resistant to multidrugs,
which becomes a great healthcare and public concern. Previous studies showed that quorum sensing signal DSF
(diffusible signal factor) not only modulates bacterial antibiotic resistance through intraspecies signaling, but also
affects bacterial antibiotic tolerance through interspecies communication. These findings motivate us to exploit the
possibility of using DSF and its structurally related molecules as adjuvants to influence antibiotic susceptibility of
bacterial pathogens.
Results: In this study, we have demonstrated that DSF signal and its structurally related molecules could be used
to induce bacterial antibiotic susceptibility. Exogenous addition of DSF signal (cis-11-methyl-2-dodecenoic acid) and
its structural analogues could significantly increase the antibiotic susceptibility of Bacillus cereus, possibly through
reducing drug-resistant activity, biofilm formation and bacterial fitness. The synergistic effect of DSF and its structurally
related molecules with antibiotics on B. cereus is dosage-dependent. Combination of DSF with gentamicin showed an
obviously synergistic effect on B. cereus pathogenicity in an in vitro model. We also found that DSF could increase the
antibiotic susceptibility of other bacterial species, including Bacillus thuringiensis, Staphylococcus aureus, Mycobacterium
smegmatis, Neisseria subflava and Pseudomonas aeruginosa.
Conclusion: The results indicate a promising potential of using DSF and its structurally related molecules as novel
adjuvants to conventional antibiotics for treatment of infectious diseases caused by bacterial pathogens.Background
Antibiotics, which act by either killing or stopping mi-
crobial growth, have been used extensively in the control
and prevention of infectious diseases. However, this
live-or-die selection pressure has inevitably fostered the
emergence of superbugs which are resistant to a range
of conventional antibiotics. Infections associated with
antibiotic-resistant pathogens are becoming more and
more common in clinical and nosocomial settings [1,2],
which become severe healthcare and public concerns.* Correspondence: lianhui@imcb.a-star.edu.sg
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reproduction in any medium, provided the orIn addition, antibiotics are commonly associated with a
range of adverse effects [3]. For instance, treatment
using aminoglycoside antibiotics, such as gentamicin
and kanamycin, can cause serious side effects, including
balance difficulty, hearing loss, and nephrotoxicity [4,5].
Reduction and limitation of antibiotic usage is therefore
of critical importance in clinical treatment of microbial
infections.
Combination antibiotics containing more than one
antimicrobial agent are designed to either improve effi-
cacy through synergistic action of the agents, or over-
come the bacterial resistance. This method has been
effectively used for treatment of tuberculosis, leprosy,
malaria, HIV, infections associated with cystic fibrosis,
and infective endocarditis [6-9]. Currently, antibiotic
combinations are frequently used to provide empiricaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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that effective antibiotic combinations are still limited and
superbugs are emerging rapidly, it is essential to continue
to search for effective antibiotic combinations and other
novel approaches to control infectious diseases. Recently,
using nonantibiotic molecules to enhance the antibacterial
efficacy of antibiotics offers a new kind of opportunity to
practice a previously untapped expanse of clinical treat-
ments. A few combinations of nonantibiotics with antibi-
otics showed increased activity against bacterial pathogens
in vitro and in vivo [8,10-12].
The diffusible signal factor (DSF), which was originally
found in Xanthomonas campestris pv campestris (Xcc),
represents a new family of widely conserved quorum
sensing (QS) signals in many Gram-negative bacterial
species. It has been well-established that DSF-family sig-
nals play important roles in regulation of various bio-
logical functions such as biofilm formation, motility,
virulence and antibiotic resistance [13-21]. In addition to
their key roles in intraspecies signaling, the importance
of DSF-family signals in interspecies and inter-kingdom
communication has also been recognized [18,22]. It was
reported that DSF signals from Burkholderia cenocepacia
and Stenotrophomonas maltophilia modulate the viru-
lence, antibiotic resistance and persistence of Pseudomonas
aeruginosa in the cystic fibrosis airway [23,24]. Further-
more, it was found that an DSF-family signal produced
by P. aeruginosa not only disperses its own biofilm for-
mation but could also induce dispersion of biofilms of
Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis,
Streptococcus pyogenes, Bacillus subtilis, Staphylococcus
aureus, and the yeast Candida albicans [25]. Moreover,
DSF-family signals showed a high level of potency in
interference of the morphology transition of C. albicans
[14,17,22], which is a critical feature associated with the
virulence of this pathogen.
Given the fact that biofilm formation is related to anti-
biotic resistance [26], together with the role of DSF-
family signals in regulation of bacterial biofilm formation
and antibiotic resistance, we speculate that DSF-family
signals may have a role in modulation of bacterial anti-
biotic susceptibility. In this study, we report that in the
presence of DSF signal and its derivatives, some of
which were identified as bacterial quorum sensing (QS)
signals [13,14,18,22], the minimum inhibitory concen-
trations (MIC) of a few antibiotics against the bacterial
pathogens were significantly reduced. Furthermore, we
showed that supplementation of DSF signal could sub-
stantially enhance the antimicrobial activity of gentamicin
and reduce the cytotoxicity of B. cereus in an in vitro
infection model. Our findings suggest the promising
potentials of DSF and its structurally related molecules
as putative antibiotic adjuvants for the control of bac-
terial infections.Results
DSF and its structurally related molecules increase the
antibiotic susceptibility of B. cereus
Bacillus is a genus of Gram-positive, rod-shaped bacteria.
They are ubiquitous in nature, and consisting of both
free-living and pathogenic species. Bacillus bacteria pro-
duce oval endospores to endure a wide range of extreme
environmental conditions, while keeping the capacity to
return to vegetative growth [27]. This remarkable charac-
teristics of the endospore-vegetative cell transition of
Bacillus pathogens allows them to be utilized as biological
weapons [28,29]. Interestingly, our preliminary results
showed that this morphological transition between the
vegetative cell and endospore of Bacillus species could be
stopped by exogenous addition of DSF-family signals
(Deng, unpublished data). This finding, together with the
previous observations that DSF signals are involved in
regulation of bacterial biofilm formation, antibiotic toler-
ance and fungal morphological transition [15,22-24], we
speculated that DSF-family signals may affect the bacterial
antibiotic sensitivity of Bacillus cells. To test this hypoth-
esis, we firstly chose B. cereus, which is a common human
pathogen and causes foodborne illness such as nausea,
vomiting and diarrhea [30], to assay the antibiotic suscep-
tibility in the presence of DSF signal or its derivatives
(Table 1). The result showed that except for T8-DSF, T15-
DSF and C8-DSF, all the other DSF-family signals and
structurally related molecules displayed significantly syn-
ergistic effects with gentamicin (Figure 1A), which is an
aminoglycoside and inhibits bacterial protein synthesis
mainly through binding with the 30S ribosomal subunit.
In particular, addition of T14-DSF or C15-DSF decreased
the MIC of gentamicin against B. cereus from 8.0 μg/ml
to 0.0625 μg/ml, which represents a 128-fold difference
(Figure 1A). Similarly, addition of DSF and related mole-
cules to B. cereus culture also enhanced the bacterial
susceptibility to kanamycin from 2- to 64-fold with T14-
DSF showing the strongest synergistic activity (Figure 1B).
Interestingly, kanamycin is also an aminoglycoside that in-
teracts with the 30S subunit of prokaryotic ribosomes and
inhibits protein synthesis. Compared to the strong syner-
gistic effect on gentamicin and kanamycin, DSF and related
molecules showed only moderate effects on rifampicin,
addition of these molecules increased the antibiotic
sensitivity of B. cereus up to 4-fold (Figure 1C). Differ-
ent from gentamicin and kanamycin, rifampicin inhibits
the DNA-dependent RNA polymerase in bacterial cells,
thus preventing gene transcription to generate RNA mole-
cules and subsequent translation to synthesize proteins.
The synergistic activity of DSF and its structurally related
molecules with antibiotics on B. cereus is dosage-dependent
To determine whether the synergistic activity of DSF
with antibiotics is related to its dosages, DSF was
Table 1 Chemical structure of DSF signal and its derivatives used in this study
Compound Configuration Structure References
T8-DSF trans COOH 14
T10-DSF trans COOH 14
T11-DSF trans COOH 14
T12-DSF trans COOH 14
T13-DSF trans COOH 14
T14-DSF trans COOH 14
T15-DSF trans COOH 14
C8-DSF cis COOH 14
C10-DSF cis COOH 14
C11-DSF cis COOH 14




C13-DSF cis COOH This study
C14-DSF cis COOH 14
C15-DSF cis COOH 14
S12-DSF NT COOH This study
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concentrations, and MICs of gentamicin and kanamycin
against B. cereus were tested. The results showed that
activity of DSF signal on B. cereus sensitivity to gentami-
cin and kanamycin was dependent on the final concen-
tration of the signal molecule (Figure 2A). Addition of
DSF at a final concentration from 5 – 50 μM increased
the antibiotic susceptibility of B. cereus to gentamicin by
2- to 16-fold, respectively (Figure 2A). Similarly, as shown
in Figure 2A, combination of different final concentrations
of DSF signal with kanamycin increased the synergistic
activity by 1.3- to 16-fold.
To test the dosage-dependent synergistic activity of
other DSF related molecules, we selected C13-DSF,
which was prepared abundantly in our laboratory, as a
representative molecule for further analysis. As shown in
Figure 2B, the effects of C13-DSF on B. cereus sensitivity
to gentamicin and kanamycin were also dosage-dependent.
Addition of C13-DSF at a final concentration from 10 μM
to 50 μM increased the gentamicin susceptibility of
B. cereus by 2- to 32-fold, and similarly, increased the
bacterial kanamycin susceptibility by about 2- to 16-fold
(Figure 2B).
Combination of DSF signal with gentamicin synergistically
decreases B. cereus pathogenicity in in vitro assays
We then continued to investigate the possibility of using
DSF signal as antibiotics adjuvant for the therapy of in-
fectious diseases caused by bacterial pathogens. HeLa
cells were used as the in vitro model to test the synergistic
activity of DSF signal with antibiotics against B. cereus.
Results showed that exogenous addition of gentamycinsignificantly decreased the cytotoxicity of B. cereus to
HeLa cell. For 2.5 h inoculation, the cytotoxicity of
B. cereus was reduced by 11.15%, 17.95%, and 26.9%%
with supplementation of 2, 4, and 8 μg/ml gentamycin,
respectively (Figure 3). In contrast, combination of 50 μM
DSF signal with gentamycin led to more decreased cyto-
toxicity of B. cereus to HeLa cell than addition of the anti-
biotic alone. As shown in Figure 3, the cytotoxicity of
B. cereus to HeLa cells was reduced by 26.9%, 29.15%
and 36.4 with treatment of 2, 4, and 8 μg/ml gentamycin
in combination with 50 μM DSF, respectively. As a con-
trol, we found that DSF signal showed no cytotoxicity
to HeLa cells and didn’t affect the B. cereus virulence
(Figure 3). These results not only further confirm the
synergistic effect of DSF signal with antibiotics on B. cereus,
but also highlight the potentials of using DSF and its
structurally related molecules as adjuvants to antibi-
otics for treatment of infectious diseases caused by
bacterial pathogens.
DSF signal interferes with the drug-resistant activity,
biofilm formation and persistence of B. cereus
To elucidate the mode of action of DSF-family signals
on B. cereus, we firstly analyzed the global gene expres-
sion patterns of B. cereus 10987 in the presence of DSF
signal using microarray assay. It was revealed that
addition of DSF signal significantly decreased the tran-
scripts levels of the genes encoding a series of drug
efflux systems and drug resistance proteinsof B. cereus
(Additional file 1: Figure S1, Additional file 1: Table S1),
which may likely reduce the antibiotic-resistant activity.





















































































































































































































































































Figure 1 Synergistic activity of DSF and its structurally related
molecules (50 μM) with gentamicin (A), kanamycin (B), and
rifampicin (C) against B. cereus. For each antibiotic, a series 2-fold
dilution was prepared for determination of MIC with or without DSF
or related molecule. Data shown are means of two replicates and
error bars indicate the standard deviations. The differences between
the samples with addition of 50 μM DSF or related molecule and control
are statistically significant with *p < 0.05, **p < 0.01, ***p < 0.001, as
determined by using the Student t test.
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Figure 2 Synergistic activity of different concentrations of DSF
(A) and C13-DSF (B) with gentamicin and kanamycin on B.
cereus. Data shown are means of two replicates and error bars
indicate the standard deviations. The differences between the
samples with addition of DSF or C13-DSF and control are statistically
significant with *p < 0.05, **p < 0.01, ***p < 0.001, as determined by
using the Student t test.
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growth rate of B. cereus was only slightly reduced with
addition of 50 μM DSF signal, whereas the bacterial bio-
film formation was substantially inhibited. Intriguingly,
we also discovered that DSF signal remarkably reduced
the persistence of B. cereus (Figure 4C). Addition of
50 μM DSF signal decreased the persistence rate of B.cereus by 5.5- and 8.7- fold after 4 h and 8 h incubation,
respectively (Figure 4C). As bacterial biofilm and per-
sisters are highly tolerant to different types of antibiotics,
inhibition of biofilm formation and persistence may
likely alter bacterial antibiotic susceptibility. In combin-
ation, our results suggest that DSF signal could exert
multifaceted effect on B. cereus, such as reducing the
drug-resistant activity, inhibiting biofilm formation and
attenuating bacterial persistence, which might lead to
altered bacterial susceptibility to antibiotics.
The combination effect of DSF signal with antibiotics on
other bacterial species
To study whether DSF could also influence the antibiotic
susceptibility of other bacterial species, the signal was
used to test the synergistic effect with antibiotics
against a few bacterial species in our collection, in-






























































Figure 3 The synergistic effect of DSF signal (50 μM) with
gentamicin on the virulence of B. cereus in an in vitro model.
Cytotoxicity was assayed by monitoring LDH release by the HeLa
cells infected with a MOI of about 1000. Data shown are means of
three replicates and error bars indicate the standard deviations. The
differences between the samples with DSF and without DSF are









Figure 4 Influences of exogenous addition of DSF signal on the
bacterial growth rate (A) biofilm formation (B), and persistence
(C) of B. cereus. For measurement of growth rate, the bacterial cells
were grown in the absence or presence of 50 μM DSF; while for test of
persistence, the bacterial cells were treated with10 μg/ml gentamicin
(Gm) in the absence or presence of 50 μM DSF signal. For biofilm
formation assays, DSF signal was added at different final
concentrations as indicated. Data shown are means of three replicates
and error bars indicate the standard deviations. The differences
between the samples with DSF and without DSF are statistically
significant with *p < 0.05, as determined by using the Student t test.
Deng et al. BMC Microbiology 2014, 14:51 Page 5 of 9
http://www.biomedcentral.com/1471-2180/14/51Mycobacterium smegmatis, Neisseria subflava, and
Pseudomonas aeruginosa. Among them, B. thuringiensis
belongs to B. cereus group and has been used as a bio-
pesticide for many years [31]. It is closely related to the
other two member of B. cereus group, i.e., B. anthracis
and B. cereus, which are important human pathogens
to cause anthrax and foodborne illness, respectively
[32]. S. aureus is frequently found in human respiratory
tract and on the skin. It can cause a range of serious ill-
nesses such as pneumonia, meningitis, osteomyelitis,
endocarditis, toxic shock syndrome (TSS), bacteremia,
and sepsis [33]. M. smegmatis is a useful model organ-
ism for research analysis of other Mycobacteria species,
especially M. tuberculosis. It is generally considered to
be a non-pathogenic bacterium, however, in rare cases
it may also cause diseases [34]. N. subflava is a rare
opportunistic pathogen and has been associated with
endocarditis, bacteremia, meningitis, septic arthritis, en-
dophthalmitis, and septicemia [35]. P. aeruginosa is a ubi-
quitous environmental organism that can infect animals,
plants, and insects, and is a major source of opportunistic
infections in immunocompromised patients and cystic
fibrosis individuals [36].
As shown in Table 2, addition of DSF signal at a final
concentration of 50 μM decreased the MICs of ampicillin,
rifampicin, kanamycin, gentamicin, tetracycline, chloram-
phenicol, and trimethoprim against B. thuringiensis by
75%, 75%, 93.75%, 93.75%, 50%, 50%, and 75%, respect-
ively. We then continued to test the synergistic effect of
DSF signal with antibiotics against S. aureus. Inclusion of
DSF signal at a final concentration of 50 μM caused
reduction of the MICs of ampicillin, kanamycin and
Table 2 Synergistic activity of DSF signal (50 μM) with
antibiotics against various bacterial species
MIC (μg/ml)
Bacteria Gm* Km Rm Am Tc Cm Tm
B. thuringiensis MEOH 4 32 1 1 4 4 512
DSF 0.25 2 0.25 0.25 2 2 128
S. aureus MEOH 0.125 2 0.0625 2 4 4 NA#
DSF 0.016 1 0.0625 1 4 4 NA
M. smegmatis MEOH 0.16 0.32 NA 256 0.16 6.4 0.64
DSF 0.08 0.08 NA 256 0.16 3.2 0.32
N. subflava MEOH 2 8 0.5 2 2 0.5 128
DSF 1 4 0.5 2 2 0.5 128
P. aeruginosa MEOH 1.28 128 NA 128 32 128 64
DSF 0.64 64 NA 128 32 128 64
*Abbreviations: Gm gentamicin, Km kanamycin, Rm rifampicin, Am ampicillin,
Tc tetracycline, Cm chloramphenicol, and Tm trimethoprim.
# NA means the bacterial species was not sensitive to the tested antibiotic.
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While for M. smegmatis, addition of DSF signal increased
its susceptibility to kanamycin, gentamicin, chlorampheni-
col and trimethoprim by 75%, 50%, 50% and 50%, respect-
ively (Table 2). For the synergistic effect of DSF signal
with antibiotics against the Gram-negative bacterial path-
ogens, as shown in Table 2, it was found that addition of
DSF only reduced the MICs of kanamycin and gentamicin
against N. subflava and P. aeruginosa by 50%, respectively,
but did not affect the MICs of other antibiotics against
these two pathogens. Furthermore, we also studied the
effect of DSF-family signals on the growth rate of these
bacteria, as shown in Additional file 1: Figure S2, exogen-
ous addition of DSF-family signals showed no influence on
the growth of P. aeruginosa, but they slightly affected the
growth of B. thuringiensis, S. aureus and M. smegmatis;
and inhibited the growth of N. subflava, which may affect
its synergistic effect with antibiotics on this particular
pathogen.
Discussion
Previous studies have established the significant roles of
DSF-family signals in microbial ecology as well as in in-
traspecies signaling regulation [14,17,22-24,37]. It was
reported that DSF signals could modulate various bio-
logical functions including virulence, biofilm formation,
antibiotic resistance and persistence through interspecies
communication [23,24,37]. Additionally, DSF-family sig-
nals were also found to play a role in inter-kingdom
communication by inhibiting morphological transition
of C. albicans [14,17,22]. The results from this study
present a new role of DSF and its structurally related
molecules, i.e., increasing the antibiotic susceptibility of
some bacterial species (Figure 1, Table 2). Given that
DSF at a final concentration of 5 μM, which appears tobe a physiological relevant concentration [14,22], could
substantially increase bacterial sensitivity to antibiotics
(Figure 2A), it appears plausible that DSF-family signals
may have a role in shaping local microbial ecology as
they could reduce the competitive advantage of some
community residents by down regulation of their anti-
biotic or toxin tolerance. Furthermore, our results also
suggest that DSF and its structurally related molecules
may be used as a new kind of antibiotic adjuvant for the
treatment of infectious diseases caused by bacterial path-
ogens, subjecting to further evaluation of their toxico-
logical and pharmacological properties.
DSF-family signals share a fatty acid carbon chain with
variations in chain length, double-bond configuration,
and side-chain [18]. Evidence is emerging that these
structural features may contribute to their biological
activity in intraspecies signalling and interspecies com-
munication [14,17,37]. Our study showed that the syn-
ergistic activity of DSF and its structurally related
molecules with antibiotics is influenced by their struc-
tural features. Each of these molecules has a distinct
synergistic activity among which the disparity could be up
to 128-fold (Figure 1A). As a general rule, our results
showed that the unsaturated long chain DSF related mole-
cules have better synergistic activity with antibiotics, espe-
cially the aminoglycoside antibiotics, than the short chain
and saturated molecules. Meanwhile, the synergistic ac-
tivity of DSF and related molecules may also seem to be
affected by the mode of action of antibiotics as the syner-
gistic activities of DSF and related molecules with amino-
glycoside antibiotics such as gentamicin and kanamycin
were much better than with other types of antibiotics
(Figure 1, Table 2).
It was reported that BDSF signalling system positively
regulates the antibiotic resistance of B. cenocepacia [21].
The same research group also found that addition of
DSF signal to P. aeruginosa could increase the bacterial
antibiotic tolerance to polymyxins [23]. Intriguingly, our
results suggest an opposite effect of DSF and its structur-
ally related molecules by increasing the bacterial antibiotic
susceptibility (Figure 1, Table 2). The contradictory results
may be due to the differences in the bacterial species or
strains and the antibiotics used in studies, which is evident
from our results (Table 2). It should also be noted that
DSF-family signals were shown to play dual roles in
regulation of biofilm formation as they positively con-
trol the biofilm development in some bacterial species,
and they could also disperse the biofilms of other bac-
terial species [15,19,21,37].
Our results suggest that DSF and related molecules
may influence the bacterial antibiotic susceptibility by
multiple ways, including modulation of the biofilm for-
mation, antibiotic resistant activity and bacterial persist-
ence (Figure 4; Additional file 1: Table S1). In addition,
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ecules acting as biosurfactants to influence bacterial sus-
ceptibility to antibiotics by using rhamnolipid, which is a
well characterized biosurfactants, as a control in MIC
and growth analysis. We found that rhamnolipid could
also increase the antibiotic susceptibility of B. cereus at
the final concentration of 50 μM (data not shown), but
it also inhibits bacterial growth at this concentration and
its toxicity on B. cereus cells was at least 5-fold higher
than DSF (Additional file 1: Figure S3), which compli-
cates the comparison. With all considered, at this stage
we could not rule out the possibility that DSF and re-
lated molecules may have biosurfactant property and
this property may contribute to their synergistic effects
with antibiotics. Furthermore, several lines of evidence
from this study and previous reports seem to suggest
that the signalling activity of DSF and its structurally
related molecules may contribute to their ability in
changing bacterial antibiotic susceptibility. Firstly, it was
reported that BDSF signalling system positively controls
the antibiotic resistance in B. cenocepacia, and addition
of 50 μM DSF signal increased the antibiotic resistance
of P. aeruginosa to polymyxins [21,23], indicating that
DSF-family signals are possibly widely involved in regu-
lation of bacterial antibiotic resistance. Secondly, differ-
ent from rhamnolipid which has a strong hydrophilic
head group glycosyl, DSF and related molecules only
have a very weak hydrophilic activity, suggesting that
they could not be good surfactants. This notion appears
to be supported by the different inhibitory activity of DSF
and rhamnolipid on the growth of B. cereus (Additional
file 1: Figure S3). Thirdly, our findings showed that
addition of 50 μM DSF signal showed no cytotoxicity to
HeLa cells, didn’t affect the B. cereus virulence (Figure 3),
but could significantly change the expression patterns of
many genes in B. cereus, some of which are known to
be associate with antibiotics resistance or tolerance
(Additional file 1: Table S1). Fourthly, the synergistic
activity of DSF is antibiotic specific. While DSF and its
structurally related molecules have strong synergistic
effect with gentamicin and kanamycin against B. cereus,
they showed a moderate effect with rifampicin, or even
no synergistic effect with other antibiotics such as
ampicillin, tetracycline (Data not shown), which may
not be solely explainable with biosurfactant properties.
Fifthly, the synergistic effect of DSF with antibiotics is
also bacterial species specific. We showed that DSF
signal had a strong synergistic effect with gentamicin
against B. cereus, B. thuringiensis and S. aureus, while it
had only a moderate effect with gentamicin against
M. smegmatis, N. subflava and P. aeruginosa (Figure 1,
Table 2). In particular, DSF signal did not show any
synergistic activity with any of the tested antibiotics, in-
cluding gentamicin, kanamycin, rifampicin, ampicillin,tetracycline, chloramphenicol, and trimethoprim, against
Escherichia coli (Data not shown). Finally, DSF and its
structurally related molecules share a very similarly chem-
ical structure, hydrophobic and hydrophilic properties,
suggesting that they should have similar chemical proper-
ties. However, their synergistic activities were significantly
different with disparity up to 128 folds (Figure 1A).
Taken together, the results from this study have estab-
lished the role of DSF and its structurally related mole-
cules in modulation of antibiotic susceptibility in some
but not all bacterial pathogens. It is also clear that the
synergistic activity with antibiotics is related to the
structural features of DSF-related molecules and likely
the chemical property or the mode of action of antibi-
otics. At least stage, it is not clear how DSF and its
structurally related molecules could influence bacterial
antibiotic sensitivity. Much work remains to be done to
determine whether their functionality in modulating
bacterial antibiotic sensitivity is related to their pure
chemical properties such as biosurfactant or hydropho-
bic activities, or associated with their potential roles in
interference of bacterial signalling and regulatory net-
works, or both. In this regard, DSF and its analogues
may be served as a useful tool to probe the potential
mechanisms governing bacterial sensitivity to antibiotics.
Conclusions
In summary, we showed that DSF and its structurally
related molecules could significantly increase bacterial
susceptibility to antibiotics, especially gentamycin and
kanamycin. Our data showed that the unsaturated long
chain DSF related molecules have better synergistic ac-
tivity with antibiotics, especially the aminoglycoside anti-
biotics, than the short chain and saturated molecules.
This synergistic effect is generic on both Gram-positive
and Gram-negative bacteria, but the tested Gram-positive
bacteria appeared to be more sensitive to the activity of
DSF and its structurally related molecules than the tested
Gram-negative bacteria. The findings from this study
suggest that DSF and its structurally related molecules
may be used as antibiotic adjuvants, which could be
useful for reducing the dose of antibiotics, hence min-
imizing the side effect caused by the antibiotics, and
slowing down the development of antibiotic resistance.
Methods
Bacterial growth conditions and MIC assays
Bacterial strains used in this work are listed in Additional
file 1: Table S2. Overnight cultures of bacteria were inocu-
lated at an OD600 of 0.025 in LB broth supplemented with
antibiotic in the absence and presence of DSF or its
structural analogue (Table 1). One hundred microliters
of inoculated culture were grown in each well at 28°C
or 37°C as indicated with shaking at 200 rpm for
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as the lowest concentration of antibiotic in which bac-
terial growth in the well was not measureable by deter-
mination of the turbidity at 600 nm, and determined
following the method from the Clinical and Laboratory
Standards Institute (CLSI) [38].
Bacterial growth analysis
Overnight bacterial cultures grown in LB broth were in-
oculated in the same medium to an OD600 of 0.025 in
the absence and presence of DSF or its analogue at a
final concentration of 50 μM. Three hundred microliters
of inoculated culture were grown in each well at 28°C or
37°C as indicated in Additional file 1: Table S2 in a low
intensity shaking model using the Bioscreen-C Automated
Growth Curves Analysis System (OY Growth Curves AB
Ltd., Finland).
Biofilm formation assays
Biofilm formation was assayed using 96-well polypropyl-
ene microtitre dishes. Overnight bacterial cultures grown
in LB broth were inoculated in the same medium to an
OD600 of 0.01 in the absence and presence of DSF signal
at different concentrations as indicated. One hundred
microliters of inoculated culture were grown in each
well at 37°C with shaking at 150 rpm for 18 h. The cul-
tures were removed and 200 μl of 1% crystal violet (w/v)
was added. Following staining at room temperature for
15 min, the dye was removed and the wells were rinsed
three times with water. For quantification of the attached
bacterial cells, the stained wells were decolorized with
200 μl of 95% ethanol. The quantity of crystal violet was
determined by measuring the absorbance at 595 nm.
Persistence assays
Persistence was measured by determining the number of
cfu/mL after exposure to 10 μg/mL gentamicin. Over-
night cultures were diluted 100-fold in 10 mL of fresh
medium and incubated at 37°C at 250 rpm to an OD600
of 1.0. Cultures were incubated with shaking at 150 rpm
at 37°C supplemented with gentamicin in the absence
and presence of DSF signal at a final concentration of
50 μM. For determination of cfu, 1-mL aliquots were
removed at the indicated time points and cells were
serially diluted in fresh medium and plated on solid
medium. Persisters were calculated after incubation at
37°C overnight.
Cytotoxicity assays in HeLa cell model
The synergistic effect of DSF signal with antibiotic on
the virulence of B. cereus was assayed by using HeLa
cells. HeLa cells were seeded in 24-well tissue culture
plates containing Dulbecco’s Modified Eagle Medium
(DMEM) and allowed to grow at 37°C in CO2 for about18 hours to obtain 80-90% monolayer confluency
(5.0×105 cells/well). Culture supernatants were removed
and the monolayer was washed once with PBS buffer.
Fresh bacterial cells cultured to an OD600 of 1.0 were
diluted in DMEM with or without DSF at a final con-
centration of 50 μM, which were then added to the
HeLa cell monolayers at a multiplicity of infection (MOI)
about 1000, and gentamycin was added at different final
concentrations as indicated. Cytotoxicity was determined
by measuring the release of the cytosolic enzyme lactate
dehydrogenase (LDH) into supernatants using the cyto-
toxicity detection kit (Roche).
Additional file
Additional file 1: Figure S1. Real-time PCR analysis of DSF effect on
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